US company Moderna says it is ready to begin trials for its booster COVID-19 vaccine shot, which aims to boost immunity against the virus variant first identified in South Africa.
As Jagruti Dave reports, it comes amid concerns that current vaccines are less effective against the 501.V2 strain.
IN: "The Boston-based..."
OUT: "...the original virus. ."
DUR 42 sec
CLIP: http://www.fsnradionews.com/feeds/0224Moderna-jd.mp3
As Jagruti Dave reports, it comes amid concerns that current vaccines are less effective against the 501.V2 strain.
IN: "The Boston-based..."
OUT: "...the original virus. ."
DUR 42 sec
CLIP: http://www.fsnradionews.com/feeds/0224Moderna-jd.mp3